Infectious Disease Diagnostics Market: By Component, By Disease Type, By Technology, By End User and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Infectious Disease Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Component (Reagents and Kits, Instruments, Services), By Disease Type (HIV, HBV, HCV, TB, HAIs, Respiratory Infections, STDs, COVID-19, Others), By Technology (Immunoassay, Molecular Diagnostics), By End User (Hospitals and Clinics, Diagnostic Centers, Homecare, Others) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Infectious disease diagnostics market size was valued at US$ 34,599.0 million in 2023 and is poised to grow at a CAGR of 8.6% from 2024 to 2030. By 2030, North America is expected to capture the largest share of the infectious disease diagnostics market. The market is fueled by increased infectious disease prevalence, a shift in focus from centralized laboratories to decentralized point-of-care testing, and Infectious Disease Research Diagnostics, increased prevalence of infectious disease, increased number of medical laboratories for infectious disease diagnostic testing, increased demand for point-of-care diagnostic tests, increased funding from private and government organizations for diagnostic service centers, and advancements in infectious disease diagnostic technologies.

Infectious diseases are illnesses brought on by bacteria, viruses, fungi, or parasites. In most cases, they're innocuous or even beneficial. However, some microbes can cause sickness under particular circumstances. Some infectious diseases are contagious and can be spread from one person to the next. The technique by which the causative agent of an infectious disease is discovered and often defined is known as infectious disease diagnostics. However, inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques hampers the market.

Infectious Disease Diagnostics Market Key Developments:

  • In February 2021, Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.

summary download arrow Download Free Sample

Global Infectious Disease Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.6%

Largest Market

North America

Fastest Growing Market

North America

Infectious Disease Diagnostics Market Dynamics

The infectious disease diagnostics market is surging owing to frequent acquisitions and launchings by the market players. Strategic alliances by the players, such as acquisitions, mergers, expansions, and new product launches, may enhance the company’s growth. For instance, In March 2021, Roche Diagnostics Launched Cobas SARS-CoV-2 Variant Set 1 Test to help monitor emerging coronavirus mutations.

Global Infectious Disease Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 34,599.0 million

Market CAGR

8.6%

By Component

  • Reagents and Kits
  • Instruments
  • Services

By Disease Type

  • HIV
  • HBV
  • HCV
  • TB
  • HAIs
  • Respiratory Infections
  • STDs
  • COVID-19
  • Others

By Technology

  • Immunoassay
  • Molecular Diagnostics

By End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Homecare
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The infectious disease diagnostics market size was valued at US$ 34,599.0 million in 2023

The infectious disease diagnostics market's key players are: Abbott Laboratories Becton Dickinson and Company BioMerieus SA Bio-Rad Laboratories Danaher Corporation F Hoffman-La Roche Hologic Inc. Luminex Corporation Qiagen Inc Thermo Fisher Scientific Inc. LumiraDx

The infectious disease diagnostics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Infectious Disease Diagnostics Market Introduction 
2.1.Global Infectious Disease Diagnostics Market  - Taxonomy
2.2.Global Infectious Disease Diagnostics Market  - Definitions
2.2.1.Component
2.2.2.Disease Type
2.2.3.Technology
2.2.4.End-user
2.2.5.Region
3.Global Infectious Disease Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Infectious Disease Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Infectious Disease Diagnostics Market  By Component, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Reagents and Kits
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Instruments
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Services
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Infectious Disease Diagnostics Market  By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. HIV
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. HBV
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. HCV
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. TB
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. HAIs
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Respiratory Infections
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. STDs
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. COVID-19
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
6.9. Others
6.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.9.3. Market Opportunity Analysis 
7.Global Infectious Disease Diagnostics Market  By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Immunoassay
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Molecular Diagnostics
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Infectious Disease Diagnostics Market  By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospitals and Clinics
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Diagnostic Centers
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Homecare
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Infectious Disease Diagnostics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Infectious Disease Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Component Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Reagents and Kits
10.1.2.Instruments
10.1.3.Services
10.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.HIV
10.2.2.HBV
10.2.3.HCV
10.2.4.TB
10.2.5.HAIs
10.2.6.Respiratory Infections
10.2.7.STDs
10.2.8.COVID-19
10.2.9.Others
10.3.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Immunoassay
10.3.2.Molecular Diagnostics
10.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals and Clinics
10.4.2.Diagnostic Centers
10.4.3.Homecare
10.4.4.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Infectious Disease Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Component Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Reagents and Kits
11.1.2.Instruments
11.1.3.Services
11.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.HIV
11.2.2.HBV
11.2.3.HCV
11.2.4.TB
11.2.5.HAIs
11.2.6.Respiratory Infections
11.2.7.STDs
11.2.8.COVID-19
11.2.9.Others
11.3.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Immunoassay
11.3.2.Molecular Diagnostics
11.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals and Clinics
11.4.2.Diagnostic Centers
11.4.3.Homecare
11.4.4.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Infectious Disease Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Component Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Reagents and Kits
12.1.2.Instruments
12.1.3.Services
12.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.HIV
12.2.2.HBV
12.2.3.HCV
12.2.4.TB
12.2.5.HAIs
12.2.6.Respiratory Infections
12.2.7.STDs
12.2.8.COVID-19
12.2.9.Others
12.3.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Immunoassay
12.3.2.Molecular Diagnostics
12.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals and Clinics
12.4.2.Diagnostic Centers
12.4.3.Homecare
12.4.4.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Infectious Disease Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Component Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Reagents and Kits
13.1.2.Instruments
13.1.3.Services
13.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.HIV
13.2.2.HBV
13.2.3.HCV
13.2.4.TB
13.2.5.HAIs
13.2.6.Respiratory Infections
13.2.7.STDs
13.2.8.COVID-19
13.2.9.Others
13.3.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Immunoassay
13.3.2.Molecular Diagnostics
13.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals and Clinics
13.4.2.Diagnostic Centers
13.4.3.Homecare
13.4.4.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Infectious Disease Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Component Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Reagents and Kits
14.1.2.Instruments
14.1.3.Services
14.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.HIV
14.2.2.HBV
14.2.3.HCV
14.2.4.TB
14.2.5.HAIs
14.2.6.Respiratory Infections
14.2.7.STDs
14.2.8.COVID-19
14.2.9.Others
14.3.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Immunoassay
14.3.2.Molecular Diagnostics
14.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals and Clinics
14.4.2.Diagnostic Centers
14.4.3.Homecare
14.4.4.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Abbott Laboratories
15.2.2.Becton Dickinson and Company
15.2.3.BioMerieus SA
15.2.4.Bio-Rad Laboratories
15.2.5.Danaher Corporation
15.2.6.F Hoffman-La Roche
15.2.7.Hologic Inc.
15.2.8.Luminex Corporation
15.2.9.Qiagen Inc
15.2.10.Thermo Fisher Scientific Inc.
15.2.11.LumiraDx
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Abbott Laboratories
  • Becton Dickinson and Company
  • BioMerieus SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F Hoffman-La Roche
  • Hologic Inc.
  • Luminex Corporation
  • Qiagen Inc
  • Thermo Fisher Scientific Inc.
  • LumiraDx

Related Industry Reports

Sexual Transmitted Infections Screening Market

Infectious Diseases Point Of Care Poc Diagnostic Market

Poc Immunoassay Testing Market

Global Molecular Diagnostics Market